There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Chimerix (CMRX – Research Report), Travere Therapeutics (TVTX – Research Report) and Karuna Therapeutics (KRTX – Research Report) with bullish sentiments.
Chimerix (CMRX)
JonesTrading analyst Soumit Roy reiterated a Buy rating on Chimerix today and set a price target of $5.00. The company’s shares closed last Thursday at $1.86, close to its 52-week low of $1.27.
According to TipRanks.com, Roy is a 4-star analyst with an average return of
Chimerix has an analyst consensus of Strong Buy, with a price target consensus of $7.67.
See the top stocks recommended by analysts >>
Travere Therapeutics (TVTX)
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Travere Therapeutics, with a price target of $36.00. The company’s shares closed last Thursday at $21.18, close to its 52-week low of $20.49.
According to TipRanks.com, Arce is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Travere Therapeutics with a $38.40 average price target, representing an 82.1% upside. In a report issued on October 20, SVB Securities also maintained a Buy rating on the stock with a $38.00 price target.
Karuna Therapeutics (KRTX)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Karuna Therapeutics, with a price target of $315.00. The company’s shares closed last Thursday at $218.81.
According to TipRanks.com, Butler is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Karuna Therapeutics with a $286.76 average price target, which is a 34.3% upside from current levels. In a report issued on October 21, Berenberg Bank also initiated coverage with a Buy rating on the stock with a $282.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CMRX:
- Software Effective Solutions’ (OTC: SFWJ) Medcana Acquires Controlling Stake in Eko2o Environmental
- Republic Bank to open new store in Broomall, PA
- Actinium Pharmaceuticals (ATNM) Receives a Buy from B.Riley Financial
- New Buy Rating for Apple (AAPL), the Technology Giant
- JonesTrading Keeps Their Buy Rating on Aeglea Biotherapeutics (AGLE)
